The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had ...

Ranitidine was also widely available in generic form from several manufacturers before the NDMA contamination was identified and the FDA banned sales in 2020. The link with cancer has been ...

Financial details of the accords weren’t immediately available. The deal is likely to reassure investors, who have seen other ...

NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

CASE DETAILS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market "[b]ased on information available at the time and correspondence with ...

CASE DETAILS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market "[b]ased on information available at the time and correspondence with ...